CIM
GILD icon

Cetera Investment Management’s Gilead Sciences GILD Stock Holding History

Cetera Investment Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-7,374
Closed -$518K – 24
2017
Q2 		$518K Sell
7,374
-618
-8% -$41.1K 0.65% 44
2017
Q1 		$543K Sell
7,992
-3,640
-31% -$256K 0.62% 57
2016
Q4 		$833K Sell
11,632
-2,079
-15% -$155K 0.62% 57
2016
Q3 		$1.08M Buy
13,711
+1,634
+14% +$133K 0.7% 52
2016
Q2 		$1.01M Sell
12,077
-873
-7% -$77.5K 0.59% 60
2016
Q1 		$1.18M Sell
12,950
-679
-5% -$61.2K 0.61% 58
2015
Q4 		$1.38M Buy
+13,629
New +$1.42M 0.56% 67

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Cetera Investment Management's GILD Position: Q3 2017 in Review

Cetera Investment Management sold out of Gilead Sciences (GILD) in Q3 2017, closing a stake of 7,374 shares — an estimated $518K sold.

Cetera Investment Management first reported a position in GILD in Q4 2015 and held it in 7 quarters. The position peaked at $1.38M in Q4 2015. 1,505 funds tracked by Wall St. Rank hold GILD as of Q3 2017.

  • Cetera Investment Management reported no remaining Gilead Sciences position as of Q3 2017 after selling out during the quarter.
  • Cetera Investment Management sold 7,374 Gilead Sciences shares in Q3 2017, an estimated $518K.
  • Cetera Investment Management first reported a position in Gilead Sciences in Q4 2015 and held it in 7 quarters.
  • Cetera Investment Management's Gilead Sciences position peaked at $1.38M in Q4 2015.
  • 1,505 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2017.

Based on Cetera Investment Management's 13F filing for Q3 2017.